MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 165421 to 165440 of 166,322 approvalsPage 8272 of 8317

碘[125I]游离甲状腺素放射免疫分析药盒

Approval Number: 国药准字S20060033
Registration: Aug 19, 2019

Tinidazole Capsules

Approval Number: 国药准字H41022153
Registration: Aug 16, 2019

Sodium Chloride Injection

Approval Number: 国药准字H22023636
Registration: Aug 16, 2019

Oxygen

Approval Number: 国药准字H20103546
Registration: Aug 16, 2019

Calcium Chloride Injection

Approval Number: 国药准字H20093715
Registration: Aug 16, 2019

Sodium Chloride Injection

Approval Number: 国药准字H20054339
Registration: Aug 16, 2019

Fat Emulsion Injection(C14~24)

Approval Number: 国药准字H22025536
Registration: Aug 16, 2019

关节止痛膏

Approval Number: 国药准字Z41020333
Registration: Aug 16, 2019

Ozagrel Sodium for Injection

Approval Number: 国药准字H20093851
Registration: Aug 16, 2019

Oxygen

Approval Number: 国药准字H51023997
Registration: Aug 16, 2019

Lidocaine Hydrochloride Injection

Approval Number: 国药准字H41023668
Registration: Aug 16, 2019

Ozagrel Sodium for Injection

Approval Number: 国药准字H20093929
Registration: Aug 16, 2019

Sodium Chloride Injection

Approval Number: 国药准字H22023635
Registration: Aug 16, 2019

辛芩胶囊

Approval Number: 国药准字Z20090965
Registration: Aug 14, 2019

护肝宁丸

Approval Number: 国药准字Z20090438
Registration: Aug 14, 2019

Benzylpenicillin Sodium for Injection

Approval Number: 国药准字H35020273
Registration: Aug 14, 2019

Benzylpenicillin Potassium for Injection

Approval Number: 国药准字H35020269
Registration: Aug 14, 2019

Benzylpenicillin Sodium for Injection

Approval Number: 国药准字H35020272
Registration: Aug 14, 2019

Adalimumab Solution for Injection

Approval Number: S20170019
Registration: Aug 14, 2019

阿胶养血颗粒

Approval Number: 国药准字Z20194090
Registration: Aug 14, 2019

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.